BALA CYNWYD, Pa.--(BUSINESS WIRE)--March 28, 2006--Duska Therapeutics, Inc. (OTCBB:DSKT), a biopharmaceutical company focused on the development of diagnostic and therapeutic products based on P2 receptors-related technologies, today announced that it has named Wayne Lorgus as its new chief financial officer effective April 1, 2006. Mr. Lorgus replaces Mark Reynolds, who resigned as of March 31, 2006.
